Track Your Future Recoveries Withsnaptrade iconConnect Account

Emergent Biosolutions Inc. Settlement
(NYSE: EBS)
Settlement

Claim Deadline: February 04, 2025

Settlement Fund: $40,000,000

Settlement Class

All persons or entities that purchased or otherwise acquired the common stock of Emergent BioSolutions Inc. (“Emergent”) (NYSE: EBS) between March 10, 2020 and November 4, 2021, both dates inclusive.

Important Documents

Settlement Status

Preliminarily Approved

Class Period

March 09, 2020 - February 02, 2022

Settlement Hearing Date

February 27, 2025

Opt-Out Deadline

February 04, 2025

Claims Admin

Strategic Claims Services
P.O. Box 230, 600 N. Jackson St., Ste. 205 Media, PA 19063
+1 866-274-4004
info@strategicclaims.net

Levi & Korsinsky did not act as lead counsel or otherwise participate in litigating the above class action and provides this information to remind class members of the deadline to submit a claim for a share of any of the settlement fund.